These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25136913)

  • 21. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.
    Testa F; Maguire AM; Rossi S; Pierce EA; Melillo P; Marshall K; Banfi S; Surace EM; Sun J; Acerra C; Wright JF; Wellman J; High KA; Auricchio A; Bennett J; Simonelli F
    Ophthalmology; 2013 Jun; 120(6):1283-91. PubMed ID: 23474247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manufacturing and regulatory strategies for clinical AAV2-hRPE65.
    Wright JF; Wellman J; High KA
    Curr Gene Ther; 2010 Oct; 10(5):341-9. PubMed ID: 20712582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.
    Colella P; Auricchio A
    Hum Gene Ther; 2012 Aug; 23(8):796-807. PubMed ID: 22734691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration.
    Fuller-Carter PI; Basiri H; Harvey AR; Carvalho LS
    BioDrugs; 2020 Dec; 34(6):763-781. PubMed ID: 33136237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
    Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Outcomes of the First in Vivo Gene Therapy for RPE65-Mediated Retinitis Pigmentosa.
    Kwak JJ; Kim HR; Byeon SH
    Yonsei Med J; 2022 Jul; 63(7):701-705. PubMed ID: 35748082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
    Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
    Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa.
    Alves CH; Wijnholds J
    Methods Mol Biol; 2018; 1715():135-151. PubMed ID: 29188511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
    Keeler AM; Flotte TR
    Annu Rev Virol; 2019 Sep; 6(1):601-621. PubMed ID: 31283441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The eyes have it.
    Brenner M
    Mol Ther; 2010 Mar; 18(3):451-2. PubMed ID: 20195259
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonintegrating Gene Therapy Vectors.
    Athanasopoulos T; Munye MM; Yáñez-Muñoz RJ
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):753-770. PubMed ID: 28895845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary Retinal Dystrophy.
    Hohman TC
    Handb Exp Pharmacol; 2017; 242():337-367. PubMed ID: 28035529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence.
    Sumaroka A; Garafalo AV; Semenov EP; Sheplock R; Krishnan AK; Roman AJ; Jacobson SG; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2551-2562. PubMed ID: 31212307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV9 targets cone photoreceptors in the nonhuman primate retina.
    Vandenberghe LH; Bell P; Maguire AM; Xiao R; Hopkins TB; Grant R; Bennett J; Wilson JM
    PLoS One; 2013; 8(1):e53463. PubMed ID: 23382846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.
    Ku CA; Chiodo VA; Boye SL; Goldberg AF; Li T; Hauswirth WW; Ramamurthy V
    Hum Mol Genet; 2011 Dec; 20(23):4569-81. PubMed ID: 21880665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee.
    Coussa RG; Lopez Solache I; Koenekoop RK
    Ophthalmic Genet; 2017; 38(1):7-15. PubMed ID: 28095138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.
    Le Meur G; Lebranchu P; Billaud F; Adjali O; Schmitt S; Bézieau S; Péréon Y; Valabregue R; Ivan C; Darmon C; Moullier P; Rolling F; Weber M
    Mol Ther; 2018 Jan; 26(1):256-268. PubMed ID: 29033008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina.
    Hori T; Fukutome M; Maejima C; Matsushima H; Kobayashi K; Kitazawa S; Kitahara R; Kitano K; Kobayashi K; Moritoh S; Koike C
    Biochem Biophys Res Commun; 2019 Jul; 515(1):222-227. PubMed ID: 31146917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.